SILYMARIN (35%) 140 MG + L-ORNITHINE L-ASPARTATE 150 MG + PYRIDXINE HCL 3 MG + FOLIC ACID 1.5 MG TABLET

DESCRIPTION

Silyfol Tablet (Silymarin (35%) 140 mg + L-ornithine L-aspartate 150 mg + Pyridxine HCL 3 mg + Folic acid 1.5 mg) hepatoprotective formulation is designed to support and protect liver function in hepatic stress conditions. Silyfol Tablet (Silymarin (35%) 140 mg + L-ornithine L-aspartate 150 mg + Pyridxine HCL 3 mg + Folic acid 1.5 mg) helps improve the liver’s detoxification process, supports healthy metabolic activity and assists in reducing oxidative stress. The formulation also promotes regeneration of liver cells, improves appetite and energy levels, and helps maintain overall liver health and wellbeing.

INDICATION

• Fatty Liver Disorders – Silyfol Tablet (Silymarin (35%) 140 mg + L-ornithine L-aspartate 150 mg + Pyridxine HCL 3 mg + Folic acid 1.5 mg) helps support healthy liver function and assists in reducing fat accumulation in the liver.

• Hepatic Stress Conditions – Silyfol Tablet (Silymarin (35%) 140 mg + L-ornithine L-aspartate 150 mg + Pyridxine HCL 3 mg + Folic acid 1.5 mg) provides protection to liver cells during conditions associated with hepatic stress and impaired liver function.

• Alcoholic Liver Damage – Silyfol Tablet (Silymarin (35%) 140 mg + L-ornithine L-aspartate 150 mg + Pyridxine HCL 3 mg + Folic acid 1.5 mg) helps protect the liver from oxidative damage caused by excessive alcohol consumption and supports liver recovery.

• Drug Induced Hepatotoxicity – Silyfol Tablet (Silymarin (35%) 140 mg + L-ornithine L-aspartate 150 mg + Pyridxine HCL 3 mg + Folic acid 1.5 mg) assists in protecting the liver from damage caused by prolonged medication use or toxic substances.

• Loss of Appetite – Silyfol Tablet (Silymarin (35%) 140 mg + L-ornithine L-aspartate 150 mg + Pyridxine HCL 3 mg + Folic acid 1.5 mg) helps improve appetite and supports better digestion and nutritional intake.

• Weakness & Fatigue – Silyfol Tablet (Silymarin (35%) 140 mg + L-ornithine L-aspartate 150 mg + Pyridxine HCL 3 mg + Folic acid 1.5 mg) supports energy metabolism and helps reduce weakness associated with liver dysfunction.

• Liver Detoxification Support – Silyfol Tablet (Silymarin (35%) 140 mg + L-ornithine L-aspartate 150 mg + Pyridxine HCL 3 mg + Folic acid 1.5 mg) assists in natural detoxification processes and promotes elimination of harmful toxins from the body.

• Elevated Liver Enzymes – Silyfol Tablet (Silymarin (35%) 140 mg + L-ornithine L-aspartate 150 mg + Pyridxine HCL 3 mg + Folic acid 1.5 mg) helps maintain healthy liver enzyme levels and supports normal liver activity.

• Chronic Liver Disorders – Silyfol Tablet (Silymarin (35%) 140 mg + L-ornithine L-aspartate 150 mg + Pyridxine HCL 3 mg + Folic acid 1.5 mg) provides nutritional and antioxidant support in long term liver related conditions.

• Nutritional Deficiency Associated Liver Conditions – Silyfol Tablet (Silymarin (35%) 140 mg + L-ornithine L-aspartate 150 mg + Pyridxine HCL 3 mg + Folic acid 1.5 mg) helps improve nutritional balance and supports overall liver health and recovery.

MACHANISM OF ACTION

• Silymarin – Acts as a potent hepatoprotective and antioxidant agent by stabilizing hepatocyte membranes, scavenging free radicals and promoting regeneration of damaged liver cells.

• L-Ornithine L-Aspartate – Enhances ammonia detoxification by stimulating the urea cycle, thereby improving hepatic metabolism and reducing hepatic stress.

• Pyridoxine HCl – Functions as an essential coenzyme in protein and amino acid metabolism, supporting enzymatic activity, energy production and metabolic balance.

• Folic Acid – Supports nucleic acid synthesis, cellular repair and hematopoietic function, thereby improving nutritional status and overall hepatocellular recovery.

SIDE EFFECTS OF SILYFOL TABLET

Major & minor side effects for Silyfol Tablet

• Dizziness
• Nausea or Vomiting
• Excessive gas in stomach
• Indigestion

PRECAUTION

Silyfol Tablet (Silymarin (35%) 140 mg + L-ornithine L-aspartate 150 mg + Pyridxine HCL 3 mg + Folic acid 1.5 mg) with caution in patients with severe hepatic or renal impairment and under medical supervision during pregnancy or lactation. Regular monitoring of liver function may be advised during prolonged therapy. Avoid alcohol consumption and do not exceed the recommended dosage.

DISCLAIMER
 

The information on this website is provided for general informational purposes only and is not medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Consult a qualified healthcare provider for personalized advice. We do not endorse any specific products, treatments, or services mentioned.